Top 20 of Osteosarcoma

Article title # Publications/# Citations

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

1986 Oct 16-22: DMAlbert; RBernards; TPDryja; SHFriend; JMRapaport; SRogelj; RAWeinberg;


Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

2007: SAmigorena; FAndré; LApetoh; FJBarrat; JBourhis; AChompret; FClavel-Chapelon; ACriollo; ... SDelaloge; FGhiringhelli; VJoulin; GKroemer; FLevi; RLidereau; MCMaiuri; GMignot; JPMira; CNogues; MObeid; COrtiz; BRyffel; PSaftig; PSaulnier; ATesnière; TTursz; EUllrich; HYang; LZitvogel;


Cancer. Addiction to oncogenes--the Achilles heal of cancer.

2002: IBWeinstein;


Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

1993: MEEwen; JKato; DMLivingston; HMatsushime; CJSherr; HKSluss;


Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor.

1985: MDPierschbacher; RPytela; ERuoslahti;


The biology of platelet-derived growth factor.

1986: DFBowen-Pope; EWRaines; RRoss;


Retroviral recombination and reverse transcription.

1990: WSHu; HMTemin;


DNA helicases Sgs1 and BLM promote DNA double-strand break resection.

2008: JRChapman; SGravel; SPJackson; CMagill;


p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

2000: HArakawa; KMatsuda; TMori; YNakamura; HNishimori; KOda; KTamai; TTanaka; ... CTanikawa; YTaya; TTokino;


Physical interaction of the retinoblastoma protein with human D cyclins.

1993: AArnold; SFDowdy; PWHinds; KLouie; SIReed; RAWeinberg;


p53 functions as a cell cycle control protein in osteosarcomas.

1990: SJBaker; BBressac; LDiller; MGebhardt; MAGryka; JKassel; GLitwak; CENelson; MOztürk; BVogelstein;


A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

1999: TJHope; GSJimenez; NDMarchenko; UMMoll; JMStommel; GMWahl;


Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.

2002: CCooper; ETKeller; LKMcCauley; KJPienta; NSTaichman; RSTaichman;


Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

2002: SSBielack; GDelling; GUExner; SFlege; KHelmke; HJürgens; BKempf-Bielack; RKotz; ... MSalzer-Kuntschik; MWerner; WWinkelmann; KWinkler; AZoubek;


The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

1991: DWGoodrich; EYLee; WHLee; YWQian; NPWang;


Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

1996: ASJun; YLKim; IATrounce; DCWallace;


Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

1988: RBookstein; PLChen; TFriedmann; HJHuang; EYLee; WHLee; JYShew; JKYee;


Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.

1983: TCurran; RMüller; CVan Beveren; Fvan Straaten; IMVerma;


Molecular cloning of a new transforming gene from a chemically transformed human cell line.

1984 Sep 6-11: DGBlair; CSCooper; CMCroce; KHuebner; MPark; MATainsky; GFVande Woude;


p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

1996: XChen; LJayaraman; LJKo; CPrives;